{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-085650","form_type":"8-K","ticker":"IOVA","cik":"0001425205","company_name":"IOVANCE BIOTHERAPEUTICS, INC.","filed_at":"2025-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.959808+00:00","generated_at":"2026-05-17T09:11:08.929689+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Iovance posts updated corporate presentation for August 2025; no specific details disclosed","bullets":["Company filed an 8-K announcing a revised corporate presentation dated August 2025.","Presentation is used at healthcare conferences and for discussions with analysts and stockholders.","Exhibit 99.1 incorporated by reference but full content not provided in this filing excerpt.","No financial or clinical milestones were explicitly stated in the filing body."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-085650","json":"https://secwatch.observer/filing/0001104659-25-085650.json","markdown":"https://secwatch.observer/filing/0001104659-25-085650.md","text":"https://secwatch.observer/filing/0001104659-25-085650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925085650/0001104659-25-085650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925085650/tm2524604d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:11:08.929689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}